Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

1. Troya, J.
2. Pousada, G.
3. Micán, R.
4. Galera, C.
5. Sanz, J.
6. de los Santos, I.
7. Dueñas, C.
8. Cabello, N.
9. Martín, C.
10. Galindo, M.J.
11. Garcinuño, M.Á.
12. Pedrero-Tomé, R.
13. Buzón, L.